CA2254120A1 - 1,3-benzodioxoles substitues - Google Patents

1,3-benzodioxoles substitues Download PDF

Info

Publication number
CA2254120A1
CA2254120A1 CA002254120A CA2254120A CA2254120A1 CA 2254120 A1 CA2254120 A1 CA 2254120A1 CA 002254120 A CA002254120 A CA 002254120A CA 2254120 A CA2254120 A CA 2254120A CA 2254120 A1 CA2254120 A1 CA 2254120A1
Authority
CA
Canada
Prior art keywords
propyl
phenyl
chloro
dioxole
benzo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002254120A
Other languages
English (en)
Inventor
Aranapakam M. Venkatesan
George T. Grosu
Fuk-Wah Sum
Adam M. Gilbert
Michael S. Malamas
Gerardo D. Francisco
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth LLC
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2254120A1 publication Critical patent/CA2254120A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/14Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/18Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1896Compounds having one or more Si-O-acyl linkages

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Nouveaux composés présentant une activité antidiurétique et/ou antihyperglycémique et/ou anti-obésité, et compositions pharmaceutiques et méthodes de traitement utilisant les composés et procédés de fabrication de ces composés, qui sont de formule (II), dans laquelle R¿1? et R¿6? sont indépendamment hydrogène, alkyle en C¿1?-C¿6?, trifluorométhyle, cyano, alcoxy en C¿1?-C¿6?, ou halogène; R¿2? est hydrogène ou trialkylsilyle en C¿1?-C¿6?; R¿3? est hydrogène ou alcoxycarbonyle en C¿1?-C¿6?; ou R¿2? et R¿3? ensemble forment un noyau (a) dans lequel R' est hydrogène, alkyle en C¿1?-C¿6? ou aryle; R¿4? et R¿5? sont indépendamment hydrogène ou alkyle en C¿1?-C¿6?; R¿7? et R¿8? sont indépendamment OR¿9? ou NR¿10?R¿11?; R¿9? est hydrogène, alkyle en C¿1?-C¿12?, cycloalkyle en C¿1?-C¿12?, silylalkyle en C¿1?-C¿12?, aryle, arylakyle, alcoxyalkyle, hétéroaryle, -CHR¿12?COOR¿13?, -CHR¿12?C(O)R¿13?, -CHR¿12?CONR¿10?R¿11?, -CHR¿12?OCOOR¿13?, ou -CHR¿12?OC(O)R¿13?, à condition que R¿9? ne soit pas hydrogène à la fois dans R¿7? et R¿8?; R¿10? et R¿11? sont indépendamment hydrogène, alkyle en C¿1?-C¿12?, aralkyle, aryle, furanylalkyle, ou alcoxycarbonylalkyle; R¿12? et R¿13? sont indépendamment hydrogène, alkyle en C¿1?-C¿12?, aryle, ou aralkyle; leurs sels pharmaceutiquement acceptables, leurs énantiomères, les mélanges racémiques correspondants et les mélanges diastéréomériques correspondants.
CA002254120A 1996-05-14 1997-05-09 1,3-benzodioxoles substitues Abandoned CA2254120A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US64597096A 1996-05-14 1996-05-14
US08/645,970 1996-05-14

Publications (1)

Publication Number Publication Date
CA2254120A1 true CA2254120A1 (fr) 1997-11-20

Family

ID=24591209

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002254120A Abandoned CA2254120A1 (fr) 1996-05-14 1997-05-09 1,3-benzodioxoles substitues

Country Status (10)

Country Link
EP (1) EP0901484A1 (fr)
JP (1) JP2000510150A (fr)
KR (1) KR20000011001A (fr)
AU (1) AU730659B2 (fr)
BR (1) BR9708948A (fr)
CA (1) CA2254120A1 (fr)
HU (1) HUP9902088A2 (fr)
IL (1) IL126780A0 (fr)
NZ (1) NZ332713A (fr)
WO (1) WO1997043273A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3100977A1 (fr) 2018-05-21 2019-11-28 Constellation Pharmaceuticals, Inc. Modulateurs d'enzymes de modification de methyle, compositions et utilisations de ceux-ci
AU2020316072A1 (en) * 2019-07-24 2022-02-24 Constellation Pharmaceuticals, Inc. EZH2 inhibition in combination therapies for the treatment of cancers

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5061727A (en) * 1990-05-04 1991-10-29 American Cyanamid Company Substituted 5-(2-((2-aryl-2-hydroxyethyl)amino)propyl)-1,3-benzodioxoles
US5482971A (en) * 1993-10-01 1996-01-09 American Cyanamid Company Beta3 -adrenergic agents and their use in pharmaceutical compositions

Also Published As

Publication number Publication date
HUP9902088A2 (hu) 2001-04-28
KR20000011001A (ko) 2000-02-25
EP0901484A1 (fr) 1999-03-17
JP2000510150A (ja) 2000-08-08
AU730659B2 (en) 2001-03-08
BR9708948A (pt) 1999-08-03
NZ332713A (en) 2000-07-28
IL126780A0 (en) 1999-08-17
WO1997043273A1 (fr) 1997-11-20
AU3006797A (en) 1997-12-05

Similar Documents

Publication Publication Date Title
KR0181178B1 (ko) 항비만/항과혈당증 성질을 갖는, 치환된 1,3-벤조디옥솔 화합물
DE69926752T2 (de) Therapeutisch wirksame biaryl-derivate
EP2430006B1 (fr) Dérivés de cyclopenta[c]pyrrole-2-carboxylates, leur préparation et leur application en thérapeutique
CN1430603A (zh) 新型双环化合物
JP4585854B2 (ja) ジオキサン−2−アルキルカルバメート誘導体、その製造法および治療における適用
CN1206419A (zh) 膦酸二酯衍生物
CN104271552A (zh) 作为kappa阿片样物质受体(kor)激动剂的取代的杂环乙酰胺
DE60128239T2 (de) Oxazolylarylpropionsäure derivate und ihre verwendung als ppar agonisten
WO2021089683A1 (fr) Inhibiteurs de l'adrénorécepteur adrac2
DE60130031T2 (de) Dihydronaphthalinderivat verbindungen und arzneimittel, die diese verbindungen als wirkstoff enthalten
FR2545825A1 (fr) 1-pyrimidinyloxy-3-hetarylalkylamino-2-propanols, leur preparation et leurs utilisations therapeutiques
DE60018194T2 (de) Hydroxamsäurederivate, verfahren zu ihrer herstellung und medikamente die diese als aktiven wirkstoff enthalten
JP2000515501A (ja) 低血糖化および低脂血化用化合物群
CA2254120A1 (fr) 1,3-benzodioxoles substitues
US5914339A (en) Substituted 1,3-benzodioxoles
HU203548B (en) Process for producing benzoxazine derivatives and pharmaceutical compositions containing them
KR100699615B1 (ko) 벤족사졸 유도체 및 아데노신 수용체 리간드로서의 이들의용도
FR2643371A1 (fr) Nouveaux derives de l'acide 2-amino pentanedioique, leur procede de preparation et leur application comme medicaments
MXPA98009384A (en) 1-3, benzodioxoles sustitui
JP3481975B2 (ja) (2s,1’s,2’r)−2−(2−カルボキシ−3−置換オキシメチルシクロプロピル)グリシン及びその製造法
FR2728571A1 (fr) Nouveaux ethers d'oximes tricycliques, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent
CN1445222A (zh) 苯并吡喃类化合物、其制备方法和用途
FR2610627A1 (fr) Sels cristallins de l'acide (3s(z))-2(((1-(2-amino-4-thiazolyl)-2-((2,2-dimethyl-4-oxo-1-(sulfo-oxy)-3-azetidinyl)amino)-2-oxoethylidene)-amino)oxy)acetique, a action therapeutique
CN109843379A (zh) 取代脲及其制备和使用方法
JPH05117236A (ja) ジクロロアニリン化合物

Legal Events

Date Code Title Description
FZDE Discontinued